The Evidence Based Rheumatology Podcast

E20: Rituxan vs. Cytoxan for AAV - The RAVE Trial

This week we discuss the pivotal RAVE trial in all it's rituxan justifying glory.  I've also added a handy Box link with all of the papers I've discussed, so check it out if you'd like to follow along! Link here.

E19: Clinical Utility of a Positive ANA

Quick podcast this week on the utility of an ANA.  It's a frequent reason for referral (17% in this series) to rheumatology offices and this is a useful paper for context. Find the paper itself here.

E18: Triple Therapy for Catastrophic Antiphospholipid Syndrome

A recent retrospective study on a rare condition - catastrophic antiphospholipid syndrome - caught my eye in the Journal of Rheumatology this week.  I thought it would be a good opportunity to talk about unmeasured confounding and introduce a rare condition that new fellows need to know about.  Find the paper itself here. 

E17: Steroids and the Risk of Scleroderma Renal Crisis

Short but impactful paper this week on the association between steroids and scleroderma renal crisis.  Find the original paper here.

E16: Tocilizumab in Giant-Cell Arteritis - GIACTA

Getting back to our usual format, this week we'll discuss the GIACTA trial, which compared various schedules of tocilizumab to various schedules of placebo and prednisone.  It's an important trial that has changed the face of GCA and will be a refreshing RCT to discuss before we dive back into garbagey data next week.  

E15: The Ribosomal P Isn't Useful in NPSLE

Welcome back! This week we're doing something a little different and discussing a few important studies on the ribosomal P in neuropsychiatric SLE.  We also have theme music!  Let me know what you think about both on twitter @EBRheum. 

E14: Cardiovascular Safety of Febuxostat

Today we'll discuss an important trial on febuxostat (ulloric), which raises important concerns about its safety from a cardiovascular perspective. Be sure to tune in to the #RheumJC discussion that will be happening this Thursday! 

E13: Withdrawing HCQ in SLE

Short podcast today on an old RCT addressing the utility of hydroxychloroquine (plaquenil) in lupus. It's an oldie but goodie and one that I enjoyed talking about. 

E12: ACR 2015 Workforce Study - the Rheumageddon!

This week we'll discuss the recently published ACR Workforce Study, which estimates a substantial deficit in the workforce by 2030.  We'll consider how dire the situation actually is - checkout the paper itself here. 

E11: Development and Validation of the HScore

This week the rheumageddon is postponed (yet again) because I researched a paper about the HScore, a scoring criteria for hemophagocytic lymphohistiocytosis (HLH), during a clinical vignettes presentation for fellowshiop. It made sense to do a podcast about that paper and save the rheumageddon for next week.  Hope y'all enjoy!  Paper can be accessed here.